Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic
A case study of the rural risk environment in Appalachian Kentucky
Dados Bibliográficos
| ID | 17680451 |
|---|---|
| Autores | Heather L Cooper (0000-0002-0521-2438, Emory University, autor correspondente), David H Cloud (0000-0001-5270-4171, Emory University), Patricia R Freeman (0000-0002-4749-6563, University of Kentucky), Monica Fadanelli (0000-0001-9962-9746, Emory University), Travis Green (University of Kentucky), Connor Van Meter (University of Kentucky), Stephanie Beane (Emory University), Umed Ibragimov (0000-0001-7111-2139, Emory University), Umedjon Ibragimov, April M Young (0000-0003-3969-3249, University of Kentucky) |
| Ano | 2020 |
| Volume | 85 |
| Páginas | 102701-102701 |
| Data de publicação | 2020-03-26 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | International Journal of Drug Policy (JOURNAL) |
| Identificadores do periódico | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2020.102701 |
| PMID | 32223985 |
| OpenAlex | W3013516348 |
| Idioma | EN |
| Citações recebidas | 20 |
| Referências citadas | 58 |
Buprenorphine · Family medicine · Medical emergency · Methadone · Opioid · Pharmacist · Psychiatry · Qualitative research · Rural area · Sociology · Thematic analysis · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Pharmacy
Qualitative Assessment of Barriers to Buprenorphine Access
Pharmacist Views Regarding the Prescription Opioid Epidemic
Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States
“Methadone at the pharmacy like Suboxone®?… It would untangle a lot of tangles.” Perspectives of North Carolinians with lived experience of opioid use on potential benefits of methadone dispensing at community pharmacies
Comparing Buprenorphine Treatment Outcomes Among Kentucky Medicaid Patients by Prescriber Specialty and Type
Capacity for sustainment of recently established syringe service programs in Appalachian Kentucky
An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the Covid‐19 pandemic
County health rankings, provider shortages, and the health of incarcerated women with opioid use disorder
Red Flags’ and ‘Red Tape’
Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies
How the rural risk environment underpins hepatitis C risk
Tackling the overdose crisis
Understanding rural risk environments for drug-related harms
Continuing increased access to buprenorphine in the United States via telemedicine after Covid-19
Socio-ecological and pharmacy-level factors associated with buprenorphine stocking at pharmacies in New York City
Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the Healing Communities Study
The War on Drugs, Racialized Capitalism, and Health Care Utilization Among White People Who Use Drugs in 22 Rural Appalachian Counties
Criminal court responses to the modern opioid and methamphetamine twindemic
Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior
Climate rentierism after coal
Evidence synthesis - The opioid crisis in Canada
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States
Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas — United States, 2013
A systematic review of multi-level stigma interventions
Transition and the HIV risk environment
HIV and risk environment for injecting drug users
Factors associated with HIV stigma and the impact of a nonrandomized multi-component video aimed at reducing HIV stigma among a high-risk population in New York City
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment
Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder
Trends in Community Pharmacy Counts and Closures Before and After the Implementation of Medicare Part D
Towards a theory of drug use contexts
People Knew They Could Come Here to Get Help”
Single room occupancy (SRO) hotels as mental health risk environments among impoverished women
Community pharmacy services for drug misuse
First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland
The ‘risk environment’
Community pharmacy services for people with drug problems over two decades in Scotland
Heroin and fentanyl overdoses in Kentucky
Racialized risk environments in a large sample of people who inject drugs in the United States
Methadone diversion as a protective strategy
Determinants of Increased Opioid-Related Mortality in the United States and Canada, 1990–2013
Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts
Spatial Access to Syringe Exchange Programs and Pharmacies Selling Over-the-Counter Syringes as Predictors of Drug Injectors' Use of Sterile Syringes
Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993–2007
The devil is here in these hills
Bearing the Cross
Using thematic analysis in psychology
Risk environments and drug harms
The social structural production of HIV risk among injecting drug users
Evidence-making interventions in health
| Obras citantes distintas | 20 |
|---|---|
| Citações por ano | 3,33 |
| Intervalo de citações | 2020 - 2026 (7) |
| Velocidade de citação | current |
| Altamente citado | Não |
| Tipos de citação | Neutras: 20 |